Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Smith

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Vaccine|April 4, 2012
Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) studyJoanne M Langley, David W Scheifele, Caroline Quach, et al.
Plos One|November 10, 2023
Phenyl-2-aminoethyl selenide ameliorates hippocampal long-term potentiation and cognitive deficits following doxorubicin treatmentAhmad H Alhowail, Matthew Eggert, Jenna Bloemer, et al.
Toxicology Mechanisms and Methods|April 24, 2019
Doxorubicin-induced neurotoxicity is associated with acute alterations in synaptic plasticity, apoptosis, and lipid peroxidationAhmad H Alhowail, Jenna Bloemer, Mohammed Majrashi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2005
Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteersShelly A McNeil, Scott A Halperin, Joanne M Langley, et al.
The Lancet. Infectious Diseases|May 14, 2021
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trialTimo Vesikari, Joanne M Langley, Nathan Segall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2018
A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune ResponseScott A Halperin, Joanne M Langley, Lingyun Ye, et al.
Cell|December 5, 2024
The genomic origin of early maize in eastern North AmericaJazmín Ramos-Madrigal, Gayle J Fritz, Bryon Schroeder, et al.
Lancet (London, England)|December 26, 2021
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trialScott A Halperin, Lingyun Ye, Donna MacKinnon-Cameron, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420May S ElSherif, Kara L Redden, Joanne M Langley, et al.
Environmental Science & Technology|January 1, 2026
Sociodemographic and Health Factors Are Associated with Antimicrobial Resistance across Eight States in the United StatesPatrick Murigu Kamau Njage, Ágnes Becsei, Ana Rita Pinheiro Marques, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Vaccine|April 4, 2012
Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) studyJoanne M Langley, David W Scheifele, Caroline Quach, et al.
Plos One|November 10, 2023
Phenyl-2-aminoethyl selenide ameliorates hippocampal long-term potentiation and cognitive deficits following doxorubicin treatmentAhmad H Alhowail, Matthew Eggert, Jenna Bloemer, et al.
Toxicology Mechanisms and Methods|April 24, 2019
Doxorubicin-induced neurotoxicity is associated with acute alterations in synaptic plasticity, apoptosis, and lipid peroxidationAhmad H Alhowail, Jenna Bloemer, Mohammed Majrashi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2005
Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteersShelly A McNeil, Scott A Halperin, Joanne M Langley, et al.
The Lancet. Infectious Diseases|May 14, 2021
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trialTimo Vesikari, Joanne M Langley, Nathan Segall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2018
A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune ResponseScott A Halperin, Joanne M Langley, Lingyun Ye, et al.
Cell|December 5, 2024
The genomic origin of early maize in eastern North AmericaJazmín Ramos-Madrigal, Gayle J Fritz, Bryon Schroeder, et al.
Lancet (London, England)|December 26, 2021
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trialScott A Halperin, Lingyun Ye, Donna MacKinnon-Cameron, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420May S ElSherif, Kara L Redden, Joanne M Langley, et al.
Environmental Science & Technology|January 1, 2026
Sociodemographic and Health Factors Are Associated with Antimicrobial Resistance across Eight States in the United StatesPatrick Murigu Kamau Njage, Ágnes Becsei, Ana Rita Pinheiro Marques, et al.
Pageof 8